Host intracellular signaling activated by viral infection, such as NF-κB and MAPKs pathways, has been reported to be involved in the aberrant pro-inflammatory response associated with poor clinical outcome [23, 54]. The gene discussed is NFKB1; the disease is viral infectious disease.